- Investing Ideas
- /
- Hong Kong Pharmaceuticals & Biotech Big Green Snowflakes
Hong Kong Pharmaceuticals & Biotech Big Green Snowflakes
Results
118
Every company on Simply Wall St ordered by total Snowflake score (not a Buy recommendation).
118 companies
Kintor Pharmaceutical
Market Cap: HK$870.5m
A clinical-stage novel drug developer, focuses on developing small molecules and biologic drugs for dermatology and oncology in the People’s Republic of China.
9939
HK$1.88
7D
-6.0%
1Y
70.9%
CK Life Sciences Int'l. (Holdings)
Market Cap: HK$8.6b
An investment holding company, researches, develops, manufactures, commercializes, and sells health and agriculture-related products in the Asia Pacific and North America.
775
HK$0.89
7D
0%
1Y
93.5%
SinoMab BioScience
Market Cap: HK$2.5b
A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of therapeutics for the treatment of immunological diseases primarily monoclonal antibody (mAb)-based biologics in Mainland China and Hong Kong.
3681
HK$1.77
7D
4.7%
1Y
37.2%
CANbridge Pharmaceuticals
Market Cap: HK$1.0b
A biopharmaceutical company, engages in the research, development, and commercialization of therapies for rare diseases and oncology indications worldwide.
1228
HK$1.98
7D
-7.5%
1Y
661.5%
Wuhan YZY Biopharma
Market Cap: HK$1.4b
A biotechnology company, develops bispecific antibody-based therapies for the treatment of cancer, cancer-related complications, and age-related ophthalmologic diseases.
2496
HK$7.01
7D
-1.1%
1Y
18.0%
Clover Biopharmaceuticals
Market Cap: HK$2.9b
A biotechnology company, engages in the research and development, manufacture, and commercialization of vaccines in Mainland China and internationally.
2197
HK$2.24
7D
1.8%
1Y
622.6%
Regent Pacific Group
Market Cap: HK$192.6m
An investment holding company, focuses on healthcare and life sciences sectors in Europe, the United States, and the Asia Pacific.
575
HK$0.66
7D
-7.0%
1Y
46.7%
Jiangsu Recbio Technology
Market Cap: HK$3.3b
A vaccine company, engages in the research, development, and commercialization of subunit vaccines in the People’s Republic of China.
2179
HK$6.99
7D
-0.3%
1Y
-16.8%
Ab&B Bio-Tech JS
Market Cap: HK$15.7b
Ab&B Bio-Tech CO., LTD. JS researchs, develops, manufactures, and sells vaccines and biological preparations that provide active immunity against diseases.
2627
HK$39.84
7D
-7.0%
1Y
n/a
Cloudbreak Pharma
Market Cap: HK$3.9b
A clinical-stage ophthalmology biotechnology company, researches and develops ophthalmic drugs for chronic eye diseases.
2592
HK$4.60
7D
-0.2%
1Y
n/a